Fresh analysis reveals that people who come off new slimming jabs like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who stop traditional lifestyle plans.
Published data in a leading health publication shows that while obese people frequently drop about a fifth of their body weight while on the medication, the mass is regained at an average rate of nearly a kilo each month upon discontinuation.
"People buying these treatments need to be informed of the risk of fast weight regain when the treatment concludes," cautioned researcher Dr. Susan Jebb.
Such speed of regain suggests a return to original mass in about a year and a half.
Comparing Treatments
The research, which looked at 37 of trials involving thousands of participants, compared the outcomes of these new drugs with conventional dieting.
Researchers point out that people who shed pounds through lifestyle changes alone generally experience a less rapid weight regain—approximately 100 grams monthly—after stopping.
The Reason for the Quick Regain
Experts propose the way of the drugs accounts for the amplified weight return.
The injections mimic a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing GLP-1 concentrations several times higher than normal may cause the body to produce less of its own natural hormone, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' results in appetite is unsuppressed, making excessive eating far more likely."
An Ongoing Disease?
Medical guidelines recommend the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Professionals say that, due to the high risk of relapse, the treatment might need to be ongoing.
This view is echoed by pharmaceutical companies, who state that the findings "highlight the long-term nature of obesity," akin to managing diseases like diabetes.
User Testimonies
Users who have come off the medication report a intense return of hunger.
"It felt as if a trigger activating and I was suddenly ravenous," said one woman.
The struggle is exacerbated if individuals have not established lasting lifestyle or habit modifications during treatment.
Significant Interest
Recent estimates suggest that millions of people in the UK have tried weight-loss jabs in the past year, with demand continuing to grow.
- Adoption is higher among females than males.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, researchers caution that while the jabs are powerful tools for shedding pounds, they are not a permanent cure and maintained weight loss relies on integrated lifestyle management.
